CLDN7 and neoplasm: In 2018, Li et al. demonstrated a previously undescribed role of CLDN7 as a clear cell renal cell carcinoma suppressor and suggested that loss of CLDN7 potentiates epithelial-mesenchymal transition and tumor progression [27].